×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | Health Topics | Vaccines | COVID | omicron | vaccines | medications

Effectiveness of COVID-19 Vaccines and Treatments Against Omicron, According to Manufacturers

scientist with syringe and omicron variant sample
(Dreamstime)

Wednesday, 08 December 2021 09:52 AM

The omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it.

South Africa's National Institute for Communicable Diseases said early epidemiological data suggested omicron was able to evade some immunity, but existing vaccines should still protect against severe disease and death.

Here's what companies that make COVID-19 vaccines and drugs have said:

MODERNA

CEO Stéphane Bancel has warned that COVID-19 vaccines are unlikely to be as effective against the omicron variant.

The company has said a new vaccine tailored for omicron should be available as soon as March.

PFIZER-BIONTECH

Companies said a three-shot course of their COVID-19 vaccine was shown to generate a neutralizing effect against the new omicron variant in a lab test.

Two vaccine doses resulted in significantly lower neutralizing antibodies but a third dose increased the neutralizing antibodies by a factor of 25, they said, adding that they can deliver an Omicron-based vaccine in March 2022.

Earlier, a lab study conducted in South Africa showed that omicron variant can partially evade protection from two doses of the PFE/BNTX shot.

JOHNSON & JOHNSON

J&J said it was testing blood serum from participants in various trials to look for neutralizing activity against the omicron variant. It was also pursuing an omicron-specific vaccine and would progress it as needed.

The company, however, remains confident in the immune responses generated by its shot against other variants to date in clinical studies, said Mathai Mammen, global head of J&J arm Janssen Research & Development.

ASTRAZENECA PLC-UNIVERSITY OF OXFORD

AstraZeneca said it was examining the impact of omicron on its vaccine, which is developed with Oxford University, and its antibody cocktail, adding it was hopeful its combination drug would retain efficacy.

REGENERON PHARMACEUTICALS INC

Its COVID-19 antibody drug could be less effective against omicron, Regeneron said.

Based on its study of omicron's individual mutations, "there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity," Regeneron said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.

ELI LILLY AND CO

The company, which also makes monoclonal antibody treatment, is working to understand the neutralization activity of its therapies on omicron, the company told Reuters in an e-mailed statement.

MERCK & Co Inc

Merck's experimental COVID-19 drug, molnupiravir, which it is co-developing with Ridgeback Biotherapeutics, should have similar activity against any new coronavirus variant, a company executive said.

NOVAVAX INC

May begin commercial manufacturing of a COVID-19 vaccine tailored for the omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.

GILEAD SCIENCES INC

Gilead has said it believes its drug - Veklury or remdesivir - will continue to be active against the omicron variant. It plans to conduct laboratory tests to confirm its analysis.

GSK-VIR BIOTECH

Laboratory analysis of the COVID-19 antibody therapy GlaxoSmithKline is developing with U.S. partner Vir Biotechnology has indicated the drug is effective against the new omicron variant, the British drugmaker said. 

© 2022 Thomson/Reuters. All rights reserved.


Health-News
The omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it. South Africa's National Institute for Communicable Diseases said early epidemiological data suggested omicron was able to evade some...
COVID, omicron, vaccines, medications, treatment, effectiveness
497
2021-52-08
Wednesday, 08 December 2021 09:52 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved